 | • レポートコード：MRC2-11QY04729 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は糖尿病・関連疾患用幹細胞療法のグローバル市場について調査・分析したレポートです。種類別（単剤療法、併用療法）市場規模、用途別（1型糖尿病、2型糖尿病、糖尿病性足潰瘍、糖尿病性腎症、糖尿病性ニューロパチー）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別糖尿病・関連疾患用幹細胞療法の競争状況、市場シェア ・世界の糖尿病・関連疾患用幹細胞療法市場：種類別市場規模 2015年-2020年（単剤療法、併用療法） ・世界の糖尿病・関連疾患用幹細胞療法市場：種類別市場規模予測 2021年-2026年（単剤療法、併用療法） ・世界の糖尿病・関連疾患用幹細胞療法市場：用途別市場規模 2015年-2020年（1型糖尿病、2型糖尿病、糖尿病性足潰瘍、糖尿病性腎症、糖尿病性ニューロパチー） ・世界の糖尿病・関連疾患用幹細胞療法市場：用途別市場規模予測 2021年-2026年（1型糖尿病、2型糖尿病、糖尿病性足潰瘍、糖尿病性腎症、糖尿病性ニューロパチー） ・北米の糖尿病・関連疾患用幹細胞療法市場分析：米国、カナダ ・ヨーロッパの糖尿病・関連疾患用幹細胞療法市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの糖尿病・関連疾患用幹細胞療法市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の糖尿病・関連疾患用幹細胞療法市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの糖尿病・関連疾患用幹細胞療法市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Athersys、Mesoblast、Caladrius Biosciences、Sanofi、Novo Nordisk ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Diabetes is the metabolic disorder that is associated with the glucose level in the blood. It is mainly divided into two types, insulin-dependent diabetes mellitus or juvenile onset (type 1) and non-insulin-dependent diabetes mellitus, or adult-onset diabetes (type 2).
NSI-566 is the stem cell therapy candidate under development by one of the key companies Neuralstem. The molecule is being developed for the treatment of individuals with diabetic neuropathy and is currently in the pre-clinical development stage. The mechanism of action of this stem cell therapy includes cell replacement that eventually leads to neurogenesis stimulation.
Market Analysis and Insights: Global Stem Cell Therapy for Diabetes and Related Conditions Market
The global Stem Cell Therapy for Diabetes and Related Conditions market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Stem Cell Therapy for Diabetes and Related Conditions Scope and Market Size
Stem Cell Therapy for Diabetes and Related Conditions market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Stem Cell Therapy for Diabetes and Related Conditions market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Athersys
Mesoblast
Caladrius Biosciences
Sanofi
Novo Nordisk
…
Market segment by Type, the product can be split into
Monotherapy
Combination Therapy
Market segment by Application, split into
Type 1 Diabetes Mellitus
Type 2 Diabetes Mellitus
Diabetic Foot Ulcer
Diabetic Nephropathy
Diabetic Neuropathy
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Stem Cell Therapy for Diabetes and Related Conditions Revenue
1.4 Market by Type
1.4.1 Global Stem Cell Therapy for Diabetes and Related Conditions Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Monotherapy
1.4.3 Combination Therapy
1.5 Market by Application
1.5.1 Global Stem Cell Therapy for Diabetes and Related Conditions Market Share by Application: 2020 VS 2026
1.5.2 Type 1 Diabetes Mellitus
1.5.3 Type 2 Diabetes Mellitus
1.5.4 Diabetic Foot Ulcer
1.5.5 Diabetic Nephropathy
1.5.6 Diabetic Neuropathy
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Stem Cell Therapy for Diabetes and Related Conditions Market Perspective (2015-2026)
2.2 Global Stem Cell Therapy for Diabetes and Related Conditions Growth Trends by Regions
2.2.1 Stem Cell Therapy for Diabetes and Related Conditions Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Stem Cell Therapy for Diabetes and Related Conditions Historic Market Share by Regions (2015-2020)
2.2.3 Stem Cell Therapy for Diabetes and Related Conditions Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Stem Cell Therapy for Diabetes and Related Conditions Market Growth Strategy
2.3.6 Primary Interviews with Key Stem Cell Therapy for Diabetes and Related Conditions Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Stem Cell Therapy for Diabetes and Related Conditions Players by Market Size
3.1.1 Global Top Stem Cell Therapy for Diabetes and Related Conditions Players by Revenue (2015-2020)
3.1.2 Global Stem Cell Therapy for Diabetes and Related Conditions Revenue Market Share by Players (2015-2020)
3.1.3 Global Stem Cell Therapy for Diabetes and Related Conditions Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Stem Cell Therapy for Diabetes and Related Conditions Market Concentration Ratio
3.2.1 Global Stem Cell Therapy for Diabetes and Related Conditions Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Stem Cell Therapy for Diabetes and Related Conditions Revenue in 2019
3.3 Stem Cell Therapy for Diabetes and Related Conditions Key Players Head office and Area Served
3.4 Key Players Stem Cell Therapy for Diabetes and Related Conditions Product Solution and Service
3.5 Date of Enter into Stem Cell Therapy for Diabetes and Related Conditions Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Stem Cell Therapy for Diabetes and Related Conditions Historic Market Size by Type (2015-2020)
4.2 Global Stem Cell Therapy for Diabetes and Related Conditions Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Stem Cell Therapy for Diabetes and Related Conditions Market Size by Application (2015-2020)
5.2 Global Stem Cell Therapy for Diabetes and Related Conditions Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Stem Cell Therapy for Diabetes and Related Conditions Market Size (2015-2020)
6.2 Stem Cell Therapy for Diabetes and Related Conditions Key Players in North America (2019-2020)
6.3 North America Stem Cell Therapy for Diabetes and Related Conditions Market Size by Type (2015-2020)
6.4 North America Stem Cell Therapy for Diabetes and Related Conditions Market Size by Application (2015-2020)
7 Europe
7.1 Europe Stem Cell Therapy for Diabetes and Related Conditions Market Size (2015-2020)
7.2 Stem Cell Therapy for Diabetes and Related Conditions Key Players in Europe (2019-2020)
7.3 Europe Stem Cell Therapy for Diabetes and Related Conditions Market Size by Type (2015-2020)
7.4 Europe Stem Cell Therapy for Diabetes and Related Conditions Market Size by Application (2015-2020)
8 China
8.1 China Stem Cell Therapy for Diabetes and Related Conditions Market Size (2015-2020)
8.2 Stem Cell Therapy for Diabetes and Related Conditions Key Players in China (2019-2020)
8.3 China Stem Cell Therapy for Diabetes and Related Conditions Market Size by Type (2015-2020)
8.4 China Stem Cell Therapy for Diabetes and Related Conditions Market Size by Application (2015-2020)
9 Japan
9.1 Japan Stem Cell Therapy for Diabetes and Related Conditions Market Size (2015-2020)
9.2 Stem Cell Therapy for Diabetes and Related Conditions Key Players in Japan (2019-2020)
9.3 Japan Stem Cell Therapy for Diabetes and Related Conditions Market Size by Type (2015-2020)
9.4 Japan Stem Cell Therapy for Diabetes and Related Conditions Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Stem Cell Therapy for Diabetes and Related Conditions Market Size (2015-2020)
10.2 Stem Cell Therapy for Diabetes and Related Conditions Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Stem Cell Therapy for Diabetes and Related Conditions Market Size by Type (2015-2020)
10.4 Southeast Asia Stem Cell Therapy for Diabetes and Related Conditions Market Size by Application (2015-2020)
11 India
11.1 India Stem Cell Therapy for Diabetes and Related Conditions Market Size (2015-2020)
11.2 Stem Cell Therapy for Diabetes and Related Conditions Key Players in India (2019-2020)
11.3 India Stem Cell Therapy for Diabetes and Related Conditions Market Size by Type (2015-2020)
11.4 India Stem Cell Therapy for Diabetes and Related Conditions Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Stem Cell Therapy for Diabetes and Related Conditions Market Size (2015-2020)
12.2 Stem Cell Therapy for Diabetes and Related Conditions Key Players in Central & South America (2019-2020)
12.3 Central & South America Stem Cell Therapy for Diabetes and Related Conditions Market Size by Type (2015-2020)
12.4 Central & South America Stem Cell Therapy for Diabetes and Related Conditions Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Athersys
13.1.1 Athersys Company Details
13.1.2 Athersys Business Overview
13.1.3 Athersys Stem Cell Therapy for Diabetes and Related Conditions Introduction
13.1.4 Athersys Revenue in Stem Cell Therapy for Diabetes and Related Conditions Business (2015-2020))
13.1.5 Athersys Recent Development
13.2 Mesoblast
13.2.1 Mesoblast Company Details
13.2.2 Mesoblast Business Overview
13.2.3 Mesoblast Stem Cell Therapy for Diabetes and Related Conditions Introduction
13.2.4 Mesoblast Revenue in Stem Cell Therapy for Diabetes and Related Conditions Business (2015-2020)
13.2.5 Mesoblast Recent Development
13.3 Caladrius Biosciences
13.3.1 Caladrius Biosciences Company Details
13.3.2 Caladrius Biosciences Business Overview
13.3.3 Caladrius Biosciences Stem Cell Therapy for Diabetes and Related Conditions Introduction
13.3.4 Caladrius Biosciences Revenue in Stem Cell Therapy for Diabetes and Related Conditions Business (2015-2020)
13.3.5 Caladrius Biosciences Recent Development
13.4 Sanofi
13.4.1 Sanofi Company Details
13.4.2 Sanofi Business Overview
13.4.3 Sanofi Stem Cell Therapy for Diabetes and Related Conditions Introduction
13.4.4 Sanofi Revenue in Stem Cell Therapy for Diabetes and Related Conditions Business (2015-2020)
13.4.5 Sanofi Recent Development
13.5 Novo Nordisk
13.5.1 Novo Nordisk Company Details
13.5.2 Novo Nordisk Business Overview
13.5.3 Novo Nordisk Stem Cell Therapy for Diabetes and Related Conditions Introduction
13.5.4 Novo Nordisk Revenue in Stem Cell Therapy for Diabetes and Related Conditions Business (2015-2020)
13.5.5 Novo Nordisk Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Stem Cell Therapy for Diabetes and Related Conditions Key Market Segments
Table 2. Key Players Covered: Ranking by Stem Cell Therapy for Diabetes and Related Conditions Revenue
Table 3. Ranking of Global Top Stem Cell Therapy for Diabetes and Related Conditions Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Stem Cell Therapy for Diabetes and Related Conditions Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Monotherapy
Table 6. Key Players of Combination Therapy
Table 7. Global Stem Cell Therapy for Diabetes and Related Conditions Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Stem Cell Therapy for Diabetes and Related Conditions Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Stem Cell Therapy for Diabetes and Related Conditions Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Stem Cell Therapy for Diabetes and Related Conditions Market Share by Regions (2015-2020)
Table 11. Global Stem Cell Therapy for Diabetes and Related Conditions Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Stem Cell Therapy for Diabetes and Related Conditions Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Stem Cell Therapy for Diabetes and Related Conditions Market Growth Strategy
Table 17. Main Points Interviewed from Key Stem Cell Therapy for Diabetes and Related Conditions Players
Table 18. Global Stem Cell Therapy for Diabetes and Related Conditions Revenue by Players (2015-2020) (Million US$)
Table 19. Global Stem Cell Therapy for Diabetes and Related Conditions Market Share by Players (2015-2020)
Table 20. Global Top Stem Cell Therapy for Diabetes and Related Conditions Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Stem Cell Therapy for Diabetes and Related Conditions as of 2019)
Table 21. Global Stem Cell Therapy for Diabetes and Related Conditions by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Stem Cell Therapy for Diabetes and Related Conditions Product Solution and Service
Table 24. Date of Enter into Stem Cell Therapy for Diabetes and Related Conditions Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Stem Cell Therapy for Diabetes and Related Conditions Market Size by Type (2015-2020) (Million US$)
Table 27. Global Stem Cell Therapy for Diabetes and Related Conditions Market Size Share by Type (2015-2020)
Table 28. Global Stem Cell Therapy for Diabetes and Related Conditions Revenue Market Share by Type (2021-2026)
Table 29. Global Stem Cell Therapy for Diabetes and Related Conditions Market Size Share by Application (2015-2020)
Table 30. Global Stem Cell Therapy for Diabetes and Related Conditions Market Size by Application (2015-2020) (Million US$)
Table 31. Global Stem Cell Therapy for Diabetes and Related Conditions Market Size Share by Application (2021-2026)
Table 32. North America Key Players Stem Cell Therapy for Diabetes and Related Conditions Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Stem Cell Therapy for Diabetes and Related Conditions Market Share (2019-2020)
Table 34. North America Stem Cell Therapy for Diabetes and Related Conditions Market Size by Type (2015-2020) (Million US$)
Table 35. North America Stem Cell Therapy for Diabetes and Related Conditions Market Share by Type (2015-2020)
Table 36. North America Stem Cell Therapy for Diabetes and Related Conditions Market Size by Application (2015-2020) (Million US$)
Table 37. North America Stem Cell Therapy for Diabetes and Related Conditions Market Share by Application (2015-2020)
Table 38. Europe Key Players Stem Cell Therapy for Diabetes and Related Conditions Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Stem Cell Therapy for Diabetes and Related Conditions Market Share (2019-2020)
Table 40. Europe Stem Cell Therapy for Diabetes and Related Conditions Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Stem Cell Therapy for Diabetes and Related Conditions Market Share by Type (2015-2020)
Table 42. Europe Stem Cell Therapy for Diabetes and Related Conditions Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Stem Cell Therapy for Diabetes and Related Conditions Market Share by Application (2015-2020)
Table 44. China Key Players Stem Cell Therapy for Diabetes and Related Conditions Revenue (2019-2020) (Million US$)
Table 45. China Key Players Stem Cell Therapy for Diabetes and Related Conditions Market Share (2019-2020)
Table 46. China Stem Cell Therapy for Diabetes and Related Conditions Market Size by Type (2015-2020) (Million US$)
Table 47. China Stem Cell Therapy for Diabetes and Related Conditions Market Share by Type (2015-2020)
Table 48. China Stem Cell Therapy for Diabetes and Related Conditions Market Size by Application (2015-2020) (Million US$)
Table 49. China Stem Cell Therapy for Diabetes and Related Conditions Market Share by Application (2015-2020)
Table 50. Japan Key Players Stem Cell Therapy for Diabetes and Related Conditions Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Stem Cell Therapy for Diabetes and Related Conditions Market Share (2019-2020)
Table 52. Japan Stem Cell Therapy for Diabetes and Related Conditions Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Stem Cell Therapy for Diabetes and Related Conditions Market Share by Type (2015-2020)
Table 54. Japan Stem Cell Therapy for Diabetes and Related Conditions Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Stem Cell Therapy for Diabetes and Related Conditions Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Stem Cell Therapy for Diabetes and Related Conditions Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Stem Cell Therapy for Diabetes and Related Conditions Market Share (2019-2020)
Table 58. Southeast Asia Stem Cell Therapy for Diabetes and Related Conditions Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Stem Cell Therapy for Diabetes and Related Conditions Market Share by Type (2015-2020)
Table 60. Southeast Asia Stem Cell Therapy for Diabetes and Related Conditions Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Stem Cell Therapy for Diabetes and Related Conditions Market Share by Application (2015-2020)
Table 62. India Key Players Stem Cell Therapy for Diabetes and Related Conditions Revenue (2019-2020) (Million US$)
Table 63. India Key Players Stem Cell Therapy for Diabetes and Related Conditions Market Share (2019-2020)
Table 64. India Stem Cell Therapy for Diabetes and Related Conditions Market Size by Type (2015-2020) (Million US$)
Table 65. India Stem Cell Therapy for Diabetes and Related Conditions Market Share by Type (2015-2020)
Table 66. India Stem Cell Therapy for Diabetes and Related Conditions Market Size by Application (2015-2020) (Million US$)
Table 67. India Stem Cell Therapy for Diabetes and Related Conditions Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Stem Cell Therapy for Diabetes and Related Conditions Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Stem Cell Therapy for Diabetes and Related Conditions Market Share (2019-2020)
Table 70. Central & South America Stem Cell Therapy for Diabetes and Related Conditions Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Stem Cell Therapy for Diabetes and Related Conditions Market Share by Type (2015-2020)
Table 72. Central & South America Stem Cell Therapy for Diabetes and Related Conditions Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Stem Cell Therapy for Diabetes and Related Conditions Market Share by Application (2015-2020)
Table 74. Athersys Company Details
Table 75. Athersys Business Overview
Table 76. Athersys Product
Table 77. Athersys Revenue in Stem Cell Therapy for Diabetes and Related Conditions Business (2015-2020) (Million US$)
Table 78. Athersys Recent Development
Table 79. Mesoblast Company Details
Table 80. Mesoblast Business Overview
Table 81. Mesoblast Product
Table 82. Mesoblast Revenue in Stem Cell Therapy for Diabetes and Related Conditions Business (2015-2020) (Million US$)
Table 83. Mesoblast Recent Development
Table 84. Caladrius Biosciences Company Details
Table 85. Caladrius Biosciences Business Overview
Table 86. Caladrius Biosciences Product
Table 87. Caladrius Biosciences Revenue in Stem Cell Therapy for Diabetes and Related Conditions Business (2015-2020) (Million US$)
Table 88. Caladrius Biosciences Recent Development
Table 89. Sanofi Company Details
Table 90. Sanofi Business Overview
Table 91. Sanofi Product
Table 92. Sanofi Revenue in Stem Cell Therapy for Diabetes and Related Conditions Business (2015-2020) (Million US$)
Table 93. Sanofi Recent Development
Table 94. Novo Nordisk Company Details
Table 95. Novo Nordisk Business Overview
Table 96. Novo Nordisk Product
Table 97. Novo Nordisk Revenue in Stem Cell Therapy for Diabetes and Related Conditions Business (2015-2020) (Million US$)
Table 98. Novo Nordisk Recent Development
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Stem Cell Therapy for Diabetes and Related Conditions Market Share by Type: 2020 VS 2026
Figure 2. Monotherapy Features
Figure 3. Combination Therapy Features
Figure 4. Global Stem Cell Therapy for Diabetes and Related Conditions Market Share by Application: 2020 VS 2026
Figure 5. Type 1 Diabetes Mellitus Case Studies
Figure 6. Type 2 Diabetes Mellitus Case Studies
Figure 7. Diabetic Foot Ulcer Case Studies
Figure 8. Diabetic Nephropathy Case Studies
Figure 9. Diabetic Neuropathy Case Studies
Figure 10. Stem Cell Therapy for Diabetes and Related Conditions Report Years Considered
Figure 11. Global Stem Cell Therapy for Diabetes and Related Conditions Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Stem Cell Therapy for Diabetes and Related Conditions Market Share by Regions: 2020 VS 2026
Figure 13. Global Stem Cell Therapy for Diabetes and Related Conditions Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Stem Cell Therapy for Diabetes and Related Conditions Market Share by Players in 2019
Figure 16. Global Top Stem Cell Therapy for Diabetes and Related Conditions Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Stem Cell Therapy for Diabetes and Related Conditions as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Stem Cell Therapy for Diabetes and Related Conditions Revenue in 2019
Figure 18. North America Stem Cell Therapy for Diabetes and Related Conditions Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Stem Cell Therapy for Diabetes and Related Conditions Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Stem Cell Therapy for Diabetes and Related Conditions Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Stem Cell Therapy for Diabetes and Related Conditions Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Stem Cell Therapy for Diabetes and Related Conditions Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Stem Cell Therapy for Diabetes and Related Conditions Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Stem Cell Therapy for Diabetes and Related Conditions Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
変形性関節症における幹細胞治療の世界市場（～2026年） Osteoarthritis is one of the chronic conditions for joints which results in the breakdown and eventual loss of the cartilage of one or more joints. This can affect joints including hips, lower back, neck, small joints of the fingers, and the base of the thumb and big toe. The expected growth is beca…- がん幹細胞治療の世界市場（～2026年） Market Analysis and Insights: Global Cancer Stem Cell Therapy Market The global Cancer Stem Cell Therapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Cancer Stem Cell Therapy Scope and Market Size Cancer Stem Cell T…
- 多発性硬化症における幹細胞治療の世界市場（～2026年） Multiple sclerosis is a nervous system disease, triggered by unidentified environmental factors that adversely affects the brain and spinal cord. It damages the myelin sheath that surrounds and protects the nerve cells. Some of the symptoms of the disease includes weakness, numbness, blurred vision,…
- 犬幹細胞治療の世界市場（～2026年） The non-invasive stem cell obtaining procedure, augmented possibility of accomplishing high quality cells, and lower price of therapy coupled with high success rate of positive outcomes have collectively made allogeneic stem cell therapy a preference for veterinary physicians. Moreover, allogeneic s…
- 糖尿病治療・ドラッグデリバリーの世界市場（～2026年） Market Analysis and Insights: Global Diabetes Therapy and Drug Delivery Market The global Diabetes Therapy and Drug Delivery market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Diabetes Therapy and Drug Delivery Scope and …